Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.650
+0.050 (1.09%)
Jan 17, 2025, 4:00 PM EST - Market closed
Cara Therapeutics Employees
Cara Therapeutics had 55 employees as of December 31, 2023. The number of employees decreased by 51 or -48.11% compared to the previous year.
Employees
55
Change (1Y)
-51
Growth (1Y)
-48.11%
Revenue / Employee
$157,927
Profits / Employee
-$1,736,818
Market Cap
21.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CARA News
- 14 days ago - CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA - Business Wire
- 24 days ago - Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement - GlobeNewsWire
- 7 months ago - These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers' - Benzinga
- 7 months ago - Cara Therapeutics discontinues study on a neurological condition as drug fails - Reuters
- 7 months ago - Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica - GlobeNewsWire
- 9 months ago - Cara Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 9 months ago - Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire